Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8073
+0.0281 (3.61%)
At close: May 22, 2026, 4:00 PM EDT
0.8000
-0.0073 (-0.90%)
After-hours: May 22, 2026, 7:10 PM EDT

Biofrontera Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.09-10.54-17.76-20.13-0.64-37.71
Depreciation & Amortization
0.780.871.151.061.170.54
Stock-Based Compensation
1.050.951.021.051.850.13
Other Adjustments
0.35-1.16-0.89-2.48-21.3711.83
Change in Receivables
0.18-1.91-0.314.934.92-12
Changes in Inventories
1.631.454.23-3.75-2.812.59
Changes in Accounts Payable
-1-0.54-1.816.420.91-0.77
Changes in Accrued Expenses
0.870.61-0.23-6.35-3.6112.48
Changes in Other Operating Activities
-1.46-3.14.33-5.643.37-3.81
Operating Cash Flow
-9.31-13.36-10.27-24.9-16.2-26.72
Capital Expenditures
-0-0-0.01-0.01-0.04-0.01
Sale of Property, Plant & Equipment
-3----
Purchases of Intangible Assets
---0.05---
Purchases of Investments
-----5.12-
Proceeds from Sale of Investments
--0.060.62--
Investing Cash Flow
33-00.62-5.16-0.01
Short-Term Debt Issued
---3.8--
Short-Term Debt Repaid
---4.32-21.34--
Net Short-Term Debt Issued (Repaid)
---4.32-17.54--
Long-Term Debt Issued
--4.0521.45--
Net Long-Term Debt Issued (Repaid)
--4.0521.45--
Issuance of Common Stock
---4.5114.0243.19
Net Common Stock Issued (Repurchased)
---4.5114.0243.19
Issuance of Preferred Stock
2.3510.8515.1---
Net Preferred Stock Issued (Repurchased)
2.3510.8515.1---
Other Financing Activities
4.25-----
Financing Cash Flow
6.610.8514.848.4114.0243.19
Net Cash Flow
4.530.494.56-15.87-7.3316.47
Free Cash Flow
-9.32-13.36-10.28-24.9-16.24-26.73
FCF Margin
-28.14%-32.04%-27.54%-73.08%-56.63%-110.90%
Free Cash Flow Per Share
-0.87-1.31-1.86-16.10-15.36-60.68
Levered Free Cash Flow
-10.27-11.25-10.36-24.5-1.64-26.69
Unlevered Free Cash Flow
-20.44-12.09-9.57-30.96-20.56-14.22
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q